Research on Cataract - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

About This Presentation
Title:

Research on Cataract - Pipeline Review, H2 2014

Description:

Big Market Research : Cataract - Pipeline Review, H2 2014 To Get More Details @ This report provides comprehensive information on the therapeutic development for Cataract, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cataract and special features on late-stage and discontinued projects. – PowerPoint PPT presentation

Number of Views:18

less

Transcript and Presenter's Notes

Title: Research on Cataract - Pipeline Review, H2 2014


1
Cataract - Pipeline Review, H2 2014 Big Market
Research
2
Report Description
Summary Global Markets Directs, Cataract -
Pipeline Review, H2 2014, provides an overview
of the Cataracts therapeutic pipeline. This
report provides comprehensive information on the
therapeutic development for Cataract, complete
with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type, along with latest updates, and
featured news and press releases. It also reviews
key players involved in the therapeutic
development for Cataract and special features on
late-stage and discontinued projects. To Get
More Details _at_ http//www.bigmarketresearch.com/ca
taract-pipeline-review-h2-2014-market
3
Report Description
Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team.
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. The report
enhances decision making capabilities and help to
create effective counter strategies to gain
competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease.
4
Scope
Scope - The report provides a snapshot of the
global therapeutic landscape of Cataract - The
report reviews key pipeline products under drug
profile section which includes, product
description, MoA and RD brief, licensing and
collaboration details other developmental
activities - The report reviews key players
involved in the therapeutics development for
Cataract and enlists all their major and minor
projects - The report summarizes all the dormant
and discontinued pipeline projects - A review of
the Cataract products under development by
companies and universities/research institutes
based on information derived from company and
industry-specific sources - Pipeline products
coverage based on various stages of development
ranging from pre-registration till discovery and
undisclosed stages - A detailed assessment of
monotherapy and combination therapy pipeline
projects - Coverage of the Cataract pipeline on
the basis of target, MoA, route of administration
and molecule type - Latest news and deals
relating related to pipeline products
5
Reasons To Buy
Reasons to buy - Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies - Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage - Develop strategic initiatives by
understanding the focus areas of leading
companies - Identify and understand important and
diverse types of therapeutics under development
for Arterial Thrombosis - Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline - Devise
corrective measures for pipeline projects by
understanding Arterial Thrombosis pipeline depth
and focus of Indication therapeutics - Develop
and design in-licensing and out-licensing
strategies by identifying prospective partners
with the most attractive projects to enhance and
expand business potential and scope Enquiry
About Report _at_ http//www.bigmarketresearch.com/re
port-enquiry/152159
6
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/cataract-pipeline
-review-h2-2014-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (855) 711-1555E-MAIL
sales_at_bigmarketresearch.com
Write a Comment
User Comments (0)
About PowerShow.com